Document is current
Any future updates will be listed below
-
Authors
Aoyama, Toru https://orcid.org/0000-0001-6803-3800
Ooki, Akira https://orcid.org/0000-0001-7618-5775
Oba, Koji
Nishikawa, Kazuhiro
Kawabata, Ryohei
Honda, Michitaka
Maeda, Hiromichi
Kanda, Mitsuro
Sugiyama, Keiji
Makiyama, Akitaka
Segami, Kenki
Takahashi, Masazumi
Shindo, Yoshiaki
Namikawa, Tsutomu
Oshima, Takashi
Katayama, Aya
Shiosakai, Kazuhito
Sakamoto, Junichi
- License Information
-
More Information
Article History
Received: 15 October 2024
Accepted: 14 March 2025
First Online: 28 April 2025
Declarations
:
: Akitaka Makiyama has received honoraria from Eli Lilly Japan K.K, Bristol Myers Squibb K.K, Ono Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., and Taiho Pharmaceutical Co., Ltd. Akira Ooki has received honoraria from Bristol Myers Squibb K.K, Ono Pharmaceutical Co., Ltd., and Astellas Pharma Inc. Aya Katayama and Kazuhito Shiosakai are employees of Daiichi Sankyo Co. Ltd.
: The study data and informed consent were obtained in accordance with the Declaration of Helsinki and were approved by the Ethics Review Board of each institution.
: Informed consent or a substitute for it was obtained from all patients for inclusion in the present study.
